Private Equity

MetroDerm has partnered with United Derm Partners, a private equity-backed dermatology platform and portfolio company of Frazier Healthcare Partners.

Here are five private equity updates since June 21:

Increasingly, private equity (PE) investors see physician practice management (PPM) and ASCs as attractive investment opportunities. This is because ASCs are well positioned to capitalize on some of the most important trends in healthcare, such as value-based care (VBC).

An affiliate of Capitol Pain Institute, an interventional pain management provider, and Iron Path Capital, a private equity firm, partnered to create a physician-led consolidation platform.

Four updates from private equity companies from the last 14 days:

The Federal Trade Commission has taken aim against a private-equity firms' healthcare deal in a move regulators say could spell trouble for other healthcare agreements the agency deems anticompetitive,  The Wall Street Journal reported recently.

Private equity company Excelsior Capital has acquired a medical office building in Kansas City, Kan., for $7 million, the company said June 15. 

Private equity-backed U.S. Urology Partners is adding Ormond Beach-based group practice Florida Urology Center.

Private equity has an increasing influence in the ASC industry as investors see opportunity in ASCs as a high-quality, low-cost site of service. 

Private equity firms have long used ASCs as investment vehicles, which they have wrapped into larger portfolios and marketed to pension funds and other big institutional investors. But across the market, those institutions are reaching their capacity for such investments.